NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
252
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Third Quarter 2023 Results Conference Call

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, announced that it will hold a conference call on Tuesday, Nov. 14, 2023, at 4:30 p.m. Eastern Time to discuss its results for the third quarter ended Sept. 30, 2023. The company will also review recent announcements, ongoing initiatives and anticipated 2024 milestones. HeartBeam CEO and Founder Branislav Vajdic, PhD, President Robert Eno and CFO Richard Brounstein will host the call, followed by a question-and-answer period. Accompanying the conference call will be a presentation, which can be viewed during the webcast or accessed via the investor relations section of the company’s website. Interested parties should visit https://nnw.fm/maaIa to access the webcast and dial 1-877-704-4453 or 1-201-389-0920 (international) and enter conference code 13741784 to join the call. A telephone replay will be available approximately three hours after the call as detailed in the announcement.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Heartbeam Inc. (BEAT) Stock Research Links

BEAT Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Stellar Elevates Leadership with Key Promotions to Drive Growth

Updated Category News Views 212

Stellar Strengthens Leadership Team for Future Success The new Executive Vice Presidents, Senior Vice President, and Vice Presidents will assume leadership roles this month. Stellar, an integrated design-build firm, proudly announces a strategic expansion of its leadership team, marking an important milestone in the company's ongoing growth and development. CEO Brian...

Continue Reading
Revolutionizing Fashion: Pixelz's Digital Twins Transform AI

Updated Category News Views 197

Transforming Fashion Content Creation Pixelz, a pioneering platform in fashion e-commerce content creation, has made headlines with its innovative approach to Artificial Intelligence (AI) featuring Digital Twins. This groundbreaking solution empowers brands to produce stunning, campaign-quality imagery rapidly and with creativity, thanks to a unique collaboration with...

Continue Reading
Alstom's First Half Results for Fiscal Year 2024/25 Unveiled

Updated Category News Views 212

Alstom's First Half Results Overview Alstom, a leading player in the transportation sector, recently shared significant updates regarding its performance in the first half of the fiscal year 2024/25. The presentation showcases their commitment to growth, innovation, and sustainability throughout the railway industry. Financial Highlights During this presentation, Alstom...

Continue Reading
Brooke Shields Leads 'Hearts of Heroes' Season 8

Updated Category News Views 10

A New Face Shines on 'Hearts of Heroes' Buckle up, folks! Brooke Shields is strapping in for the eighth season of 'Hearts of Heroes,' the award-winning show spotlighting everyday champions and first responders. Premiering on July 11, this series lands a spot in ABC's Weekend Adventure block, thrusting Shields into the limelight as she takes the baton from previous hosts...

Continue Reading
Cytokinetics' MYQORZO® Gains Approval for Hypertrophic Cardiomyopathy

Updated Category News Views 118

Cytokinetics' MYQORZO® Achieves NMPA Approval in China Cytokinetics, Incorporated (NASDAQ: CYTK) has exciting news—the approval of MYQORZO® (aficamten) by the China National Medical Products Administration (NMPA) for adults suffering from obstructive hypertrophic cardiomyopathy (oHCM). This milestone not only underscores the effectiveness of their innovative therapy...

Continue Reading